Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · IEX Real-Time Price · USD
1.960
+0.020 (1.03%)
May 17, 2024, 4:00 PM EDT - Market closed
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $78.53 million as of May 17, 2024. Its market cap has increased by 68.51% in one year.
Market Cap
78.53M
Enterprise Value
44.52M
1-Year Change
68.51%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $78.53M, a decrease of -69.38%. That is a compound annual growth rate of -36.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 78.50M | 1.03% |
May 16, 2024 | 77.70M | -0.51% |
May 15, 2024 | 78.10M | -1.51% |
May 14, 2024 | 79.30M | 1.54% |
May 13, 2024 | 78.10M | 0.51% |
May 10, 2024 | 77.70M | 1.57% |
May 9, 2024 | 76.50M | -4.49% |
May 8, 2024 | 80.10M | 4.16% |
May 7, 2024 | 76.90M | -0.90% |
May 6, 2024 | 77.60M | 3.05% |
May 3, 2024 | 75.30M | -2.46% |
May 2, 2024 | 77.20M | 1.45% |
May 1, 2024 | 76.10M | 2.15% |
Apr 30, 2024 | 74.50M | -1.06% |
Apr 29, 2024 | 75.30M | -1.05% |
Apr 26, 2024 | 76.10M | 1.06% |
Apr 25, 2024 | 75.30M | -2.96% |
Apr 24, 2024 | 77.60M | -0.51% |
Apr 23, 2024 | 78.00M | 7.59% |
Apr 22, 2024 | 72.50M | 0.97% |
Apr 19, 2024 | 71.80M | - |
Apr 18, 2024 | 71.80M | -3.10% |
Apr 17, 2024 | 74.10M | 0.54% |
Apr 16, 2024 | 73.70M | -1.07% |
Apr 15, 2024 | 74.50M | -2.49% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SHL Telemedicine | 81.79M |
Assembly Biosciences | 81.79M |
HOOKIPA Pharma | 81.00M |
Affimed | 79.95M |
Alpha Teknova | 79.81M |
MDxHealth | 78.04M |
Neuronetics | 77.99M |
BioXcel Therapeutics | 77.50M |